The Royal Pharmaceutical Society of Great Britain has published a report calling for action on medicines safety and launched a new award which recognizes significant achievement in improving drug safety in the UK. The report, The Contribution of Pharmacy to Making Britain a Safer Place to Take Medicines, calls for a five to 10 year action plan to be drawn up by pharmacists and other key health care providers to improve prescription drug safety.
Nick Barber, one of the report authors and an RPSGB council member, said: "medicines can offer great benefits, saving lives and improving patients' ability to live full and active lives." Prof Barber added that "we need to recognize that they can also have risks. If they are not taken correctly, their effectiveness can be hampered or they can be potentially harmful."
Patient safety is a concern for the National Health Service, with an estimated cost for treating preventable harm from the adverse effects of pharmaceutical products of GBP750.0 million ($1.07 billion) per year in England alone.
This article is accessible to registered users, to continue reading please register for free. A free trial will give you access to exclusive features, interviews, round-ups and commentary from the sharpest minds in the pharmaceutical and biotechnology space for a week. If you are already a registered user please login. If your trial has come to an end, you can subscribe here.
Login to your accountTry before you buy
7 day trial access
Become a subscriber
Or £77 per month
The Pharma Letter is an extremely useful and valuable Life Sciences service that brings together a daily update on performance people and products. It’s part of the key information for keeping me informed
Chairman, Sanofi Aventis UK
Copyright © The Pharma Letter 2025 | Headless Content Management with Blaze